#24-400 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Audientes A/S: Q3 2024 Financial Report
Reading Time: 4 minutes Company announcement no. 33-2024November 21, 2024 Audientes A/S (“Audientes” or the “Company”), CVR 36047631, announces its unaudited financial results for Q3 2024. The Company provides updates on progress in its key markets and adjusts its sales and financial objectives for the
Tele2 announces changes to the Group Leadership Team
Reading Time: 2 minutes Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Yogesh Malik, Executive Vice President and CTIO, will step down from his position effective from today. Yogesh joined Tele2 and the Group Leadership Team in April
Fondia Plc: Share repurchase 21.11.2024
Reading Time: < 1 minute Fondia Plc Company release 21.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 21.11.2024 Fondia Plc First North Finland Date 21.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 323 Average price/share, EUR 5,90
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 21.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024 Date 21.11.2024 Exchange transaction Buy Share class ALEX Amount 210 Average price/share 8.6500 EUR Highest
CasinoRank Explores iGaming Regulation Changes and Their Impact
Reading Time: 2 minutes November 21, 2024 — CasinoRank, a trusted authority in online casino industry, provides insights on regulatory changes shaping the global iGaming market. These changes, spanning multiple jurisdictions, are redefining the landscape for operators, players, and stakeholders worldwide. While many regions
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion
Reading Time: 2 minutes Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the
Biosergen Releases Interview with Principal Investigator Dr. Pawan Singh on Drug-Resistant Fungal Infections and BSG005
Reading Time: 2 minutes November 21, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, is pleased to announce the release of a fireside-chat-style video interview during the World Antimicrobial Resistance Awareness Week (WAAW). The video features the company’s CEO,
Arkion Wins Contract with Elvia, Norway’s Largest Distribution Grid Operator
Reading Time: 2 minutes Stockholm, Sweden – Oslo, Norway – November 21, 2024 – Arkion, a leading provider of AI-powered asset analytics, proudly announces its selection as the sole provider of detailed condition assessments for Elvia. Elvia, one of Norway’s largest electricity networks, has
Uniphore and Konecta Join Forces to Advance AI in Customer Experience and Digital Transformation
Reading Time: 4 minutes Madrid, Spain & Palo Alto, Calif., United States: Partnership is the first to deliver a real solution for scaling generative AI globally. Global Strategic Alliance to deliver industry specific AI solutions enhancing CX with hyper-personalized interactions and sentiment analysis Joint go-to-market